Genelux Corp. (GNLX)
2.66
-0.22
(-7.64%)
USD |
NASDAQ |
Aug 28, 16:00
2.665
0.00 (0.00%)
After-Hours: 20:00
Genelux Price : 2.66 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 2.87 | 2.87 | 2.65 | 2.66 | 417798.0 |
| Aug 27, 2026 | 2.72 | 2.95 | 2.72 | 2.88 | 594425.0 |
| Aug 26, 2026 | 2.73 | 2.756 | 2.64 | 2.73 | 300183.0 |
| Aug 25, 2026 | 2.73 | 2.82 | 2.67 | 2.72 | 352907.0 |
| Aug 24, 2026 | 2.70 | 2.77 | 2.57 | 2.72 | 361056.0 |
| Aug 21, 2026 | 2.78 | 2.81 | 2.684 | 2.72 | 223747.0 |
| Aug 20, 2026 | 2.72 | 2.80 | 2.62 | 2.74 | 405119.0 |
| Aug 19, 2026 | 2.64 | 2.79 | 2.63 | 2.68 | 317438.0 |
| Aug 18, 2026 | 2.70 | 2.79 | 2.555 | 2.60 | 379006.0 |
| Aug 17, 2026 | 2.76 | 2.76 | 2.63 | 2.70 | 265150.0 |
| Aug 14, 2026 | 2.65 | 2.82 | 2.58 | 2.74 | 462788.0 |
| Aug 13, 2026 | 2.70 | 2.76 | 2.61 | 2.63 | 315709.0 |
| Aug 12, 2026 | 2.70 | 2.73 | 2.54 | 2.70 | 250836.0 |
| Aug 11, 2026 | 2.75 | 2.775 | 2.55 | 2.65 | 315950.0 |
| Aug 10, 2026 | 2.66 | 2.73 | 2.62 | 2.72 | 434431.0 |
| Aug 07, 2026 | 2.72 | 2.72 | 2.52 | 2.66 | 246864.0 |
| Aug 06, 2026 | 2.51 | 2.735 | 2.50 | 2.70 | 209651.0 |
| Aug 05, 2026 | 2.85 | 2.93 | 2.50 | 2.51 | 950188.0 |
| Aug 04, 2026 | 3.00 | 3.08 | 2.78 | 2.82 | 787371.0 |
| Aug 03, 2026 | 2.97 | 2.99 | 2.91 | 2.98 | 219562.0 |
| Jul 31, 2026 | 3.04 | 3.054 | 2.87 | 2.94 | 374940.0 |
| Jul 30, 2026 | 2.89 | 3.08 | 2.83 | 3.05 | 236499.0 |
| Jul 29, 2026 | 2.95 | 2.97 | 2.80 | 2.83 | 125502.0 |
| Jul 28, 2026 | 2.93 | 2.955 | 2.85 | 2.92 | 145745.0 |
| Jul 27, 2026 | 2.96 | 2.995 | 2.89 | 2.95 | 66498.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arcutis Biotherapeutics, Inc. | 23.78 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.26 |
Price Related Metrics
| PS Ratio | 13691.48 |
| PEG Ratio | -2.366 |
| Price to Book Value | 7.446 |
| Earnings Yield | -32.63% |
| Market Cap | 119.98M |
| PEGY Ratio | -2.366 |